GERM vs. PCGG ETF Comparison

Comparison of ETFMG Treatments Testing and Advancements ETF (GERM) to Polen Capital Global Growth ETF (PCGG)

GERM

ETFMG Treatments Testing and Advancements ETF

GERM Description

GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.

Grade (RS Rating)

Last Trade

$19.16

Average Daily Volume

1,248

Number of Holdings ^*

* may have additional holdings in another (foreign) market

PCGG

Polen Capital Global Growth ETF

PCGG Description

The fund is a non-diversified, actively-managed exchange-traded fund ("ETF") that seeks to achieve its objective by investing in a focused portfolio of approximately 25 to 40 common stocks of large capitalization companies that are located anywhere in the world, including companies in both developed and emerging markets, and, in the opinion of the sub-advisor to the fund, have a sustainable competitive advantage. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$11.39

Average Daily Volume

46,347

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	GERM	PCGG
30 Days	3.00%	-0.52%
60 Days	3.68%	4.88%
90 Days	-2.06%	1.88%
12 Months	-0.17%	20.86%

0 Overlapping Holdings

	Symbol	Grade	Weight in GERM	Weight in PCGG	Overlap

GERM Overweight 2 Positions Relative to PCGG

	Symbol	Grade	Weight
	SCLX	F	0.0%
	INO	F	0.0%

GERM Underweight 9 Positions Relative to PCGG

Symbol	Grade	Weight
AMZN	C	-9.94%
GOOG	C	-8.8%
MSFT	C	-6.97%
ADBE	F	-4.73%
ABT	C	-4.32%
MA	A	-4.28%
V	C	-4.15%
WDAY	D	-3.91%
ICLR	F	-3.8%

GERM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - General